Triazine compounds as PI3 kinase and mTOR inhibitors

Details for Australian Patent Application No. 2009248997 (hide)

Owner Wyeth LLC

Inventors Chen, Zecheng; Curran, Kevin J; Zask, Arie; Shi, Mengxiao; Richard, David J; Gopalsamy, Ariamala; Venkatesan, Aranapakam M; Ayral-Kaloustian, Semiramis; Mansour, Tarek S; Dehnhardt, Christoph M; Verheijen, Jeroen C; Delos Santos, Efren G; Kaplan, Joshua A; Dos Santos, Osvaldo

Agent Spruson & Ferguson

Pub. Number AU-A-2009248997

PCT Pub. Number WO2009/143317

Priority 61/055,661 23.05.08 US

Filing date 21 May 2009

Wipo publication date 26 November 2009

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/143317 Priority application(s): WO2009/143317

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009248999-Stereoscopic measurement system and method

2009248993-Triazine compounds as PI3 kinase and mTOR inhibitors